Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Vinorelbine, epirubicin, 5-FU combo is manageable first-line chemotherapy
April 19th, 2005
Researchers in Italy report that continuous infusion with combined vinorelbine, epirubicin, and 5-fluorouracil is "an active and manageable first-line regimen for metastatic breast cancer patients." "We investigated the activity and toxicity of a combination of vinorelbine 25 mg/m2 on days 1 and 15; epirubicin 25 mg/m2 on days 1, 8, 15; and 5-fluorouracil continuous infusion at 200 mg/m2 every day, administered as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. Fifty-three patients entered the study. Cycles were repeated every 28 days," said A. Berruti and colleagues, Azienda Osped San Luigi. ...
Source: Cancer Weekly (2005-04-19)
|
